Stumpf Capital Management’s GSK GSK Stock Holding History

Stumpf Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.79M	Hold	38,120	–	–	3.34%	4
2020 Q2	$1.94M	Hold	38,120	–	–	3.47%	4
2020 Q1	$1.8M	Hold	38,120	–	–	3.1%	4
2019 Q4	$2.24M	Sell	38,120 -11,040	-22%	-$614K	1.72%	6
2019 Q3	$2.62M	Hold	49,160	–	–	2.27%	5
2019 Q2	$2.46M	Hold	49,160	–	–	2.1%	4
2019 Q1	$1.99M	Hold	49,160	–	–	2.06%	5
2018 Q4	$2.35M	Hold	49,160	–	–	2.45%	4
2018 Q3	$2.47M	Hold	49,160	–	–	2.27%	4
2018 Q2	$2.48M	Hold	49,160	–	–	2.31%	3
2018 Q1	$2.4M	Buy	49,160 +16,640	+51%	+$775K	2.4%	3
2017 Q4	$1.44M	Buy	+32,520	New	+$1.5M	1.33%	5

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Stumpf Capital Management's GSK Position: Q3 2020 in Review

Stumpf Capital Management held its GSK (GSK) position steady in Q3 2020 at 38,120 shares worth $1.79M. The position accounts for 3.34% of the portfolio, ranked #4.

Stumpf Capital Management first reported a position in GSK in Q4 2017 and has held it in 12 quarters since. The position peaked at $2.62M in Q3 2019. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Stumpf Capital Management held 38,120 shares of GSK worth $1.79M as of Q3 2020.
Stumpf Capital Management left its GSK share count unchanged in Q3 2020.
GSK made up 3.34% of Stumpf Capital Management's portfolio in Q3 2020, its #4 holding.
Stumpf Capital Management first reported a position in GSK in Q4 2017 and has held it in 12 quarters since.
Stumpf Capital Management's GSK position peaked at $2.62M in Q3 2019.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Stumpf Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.